• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.84% Nasdaq Up 0.59%

    More On RVX.TO

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    Resverlogix Corp. (RVX.TO)

    -Toronto
    2.21 Up 0.13(6.25%) 11:59AM EDT
    Add to Portfolio
    Prev Close:2.08
    Open:2.10
    Bid:2.19
    Ask:2.21
    1y Target Est:N/A
    Beta:4.93768
    Next Earnings Date:N/A
    Day's Range:2.09 - 2.33
    52wk Range:0.41 - 3.13
    Volume:47,786
    Avg Vol (3m):44,219
    Market Cap:232.22M
    P/E (ttm):N/A
    EPS (ttm):-0.22
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in CAD.

    Headlines

    » More Headlines for RVX.TO

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Apr-16) :-0.18
    Quarterly EPS Est (Jul-15) :-0.04
    Mean Recommendation*:3.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Resverlogix Corp., a clinical stage biotechnology company, develops small molecule therapeutics for Bromodomain and ExtraTerminal (BET) inhibition. The company is developing RVX-208, a small molecule selective BET domain inhibitor that is in clini... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback